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b-amyloid 1-42 (Ab1-42) is a self-assembling peptide that goes through many
conformational and morphological changes before forming the fibrils that are
deposited in extracellular plaques characteristic of Alzheimer’s disease. The
link between Ab1-42 structure and toxicity is of major interest, in particular,
the neurotoxic potential of oligomeric species. Many studies utilise reversed
(Ab42-1) and scrambled (AbS) forms of amyloid-b as control peptides. Here,
using circular dichroism, thioflavin T fluorescence and transmission electron
microscopy, we reveal that both control peptides self-assemble to form fibres
within 24 h. However, oligomeric Ab reduces cell survival of hippocampal neu-
rons, while Ab42-1 and Abs have reduced effect on cellular health, which may
arise from their ability to assemble rapidly to form protofibrils and fibrils.
Keywords: Alzheimer’s disease; amyloid fibril; amyloid-b, control;
cytotoxicity; self-assembly
A key characteristic of Alzheimer’s disease (AD) is the
deposition of b-amyloid fibrils in extracellular plaques,
as well as the intracellular accumulation of tau in neu-
rofibrillary tangles in the brain [1]. Whether Ab or tau
is the trigger or driver of the disease continues to be a
controversial topic, although there is no doubt that
both contribute to the disease pathway and progres-
sion [2]. Ab is cleaved from the amyloid precursor pro-
tein (APP) to produce several peptides of different
amino acid-length peptides including 1-39, 1-40, 1-42,
1-43 and 1-46 as well as the N-truncated Ab4-42 [3]
While Ab1-40 is the predominant species in unaffected
individuals, the ratio of Ab1-42:1-40 increases in AD
[4]. Ab1-42 is more amyloidogenic than Ab1-40
in vitro [5] and appears to show a higher level of toxic-
ity in cellular assays [6]. Furthermore, increased levels
of Ab1-42 correlate with Alzheimer’s disease in both
familial and sporadic Alzheimer’s disease patients [7].
Therefore, the self-assembly of Ab1-42 is implicated in
the cause of AD.
The cytotoxic effect of the Ab1-42 peptide is
believed to be linked to its ability to self-assemble to
form oligomers and amyloid fibrils [8]. This is sup-
ported by our recent report showing that a designed
nonassembling variant of Ab1-42 is unable to induce
cell death of hippocampal neurons [9]. The oligomeric
form is proposed to represent the toxic species leading
to neuronal dysfunction and eventual cell death [8,10].
Many studies have examined the role of Ab1-42 and
have utilised Ab42-1 or AbS as control peptides
[11,12]. These “control” peptides are chosen because
they are not expected to self-assemble or to form toxic,
oligomeric species, despite sharing amino acid compo-
sition with wild-type Ab. However, the fibrillogenesis
of these peptides and resulting structures has not been
previously analysed in detail. Furthermore, despite
being used in cellular assays as controls, the cytotoxic
nature, or lack of, has not been studied in relation to
their assembly state. Here, we have characterised the
assembly, structure and toxicity of the current
Abbreviations
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experimental controls used in Ab1-42 studies; Ab42-1
and AbS. Understanding the biophysical properties of
these peptides provides valuable information about the
ability of peptides to form toxic species and gives fur-
ther insights into how sequence relates to amyloido-
genicity and/or toxicity.
We have optimised a preparation process for the
Ab1-42 peptide allowing us to follow aggregation from
monomer to fibril consistently [8,13]. Pretreatment of
Ab1-42 is essential as self-assembly is extremely
difficult to control due to the peptides’ sensitivity to
temperature, pH, concentration and the presence of
pre-existing aggregates which can act as seeds and
accelerate assembly. Using this information, we are
able to confidently identify the time point where
Ab1-42 oligomers are most abundant in solution, and
use this information to assess the relationship between
structure and toxicity.
Here, Ab1-42, Ab42-1 and AbS were prepared in an
identical manner and their fibrillogenesis and structure
were examined using circular dichroism (CD), thiofla-
vin T fluorescence (ThT) and transmission electron
microscopy (TEM). We show that both control pep-
tides adopt b-sheet structure earlier than Ab1-42, and
also aggregate more rapidly to form mature fibrils.
The toxic effect of these peptides was investigated on
primary hippocampal neuronal cultures; as expected,
Ab1-42 oligomers showed significant toxicity. In con-
trast, the two control peptides exerted minimal cyto-
toxicity. This may arise from the formation of




Ab42-1 and AbS (Table 1) were purchased from Bachem in
powder form with free N and C termini. (AbS sequence
can differ depending on company – this sequence is sold by
Anaspec and BACHEM but scrambled sourced from rPep-
tide and Biolegend differ in sequence). 1,1,1,3,3,3-hexa-
fluoro-2-isopropanol (HFIP) films of recombinant Ab1-42
were purchased from rPeptide. Peptides were prepared in
the appropriate buffer depending on the experimental pro-
cedure being used. About 0.2 mg of peptide was solubilised
in 200 lL HFIP (Sigma Aldrich, Dorset, UK) in order to
remove any preaggregates. The solution was then vortexed
for a minute and sonicated for 5 min in a 50/60 Hz sonica-
tor. Nitrogen gas was used to evaporate the HFIP, after
which 200 lL dry dimethylsulphoxide (DMSO) (Sigma-
Aldrich) was added. The solution was again vortexed for a
minute, followed by sonication for a minute. The solutions
were added to buffer-exchange, HEPES-equilibrated
7KDMW Zeba columns with 40 lL buffer added as a
stack. The protein solution collected was kept on ice and
the absorbance at 280 nm was measured immediately with
a NanoDrop spectrophotometer using a molar coefficient
of 1490 M!1 cm!1 (value from http://web.expasy.org/protpa
ram/). All solutions were diluted to 50 lM with buffer.
Waltz algorithm analysis
The primary sequence of each peptide (Table 1) was input
in FASTA format into the Waltz algorithm http://waltz.
switchlab.org and pH was set to 7 [14]. Data were output
as a text file (.dat) and then plotted using excel.
Transmission electron microscopy
Peptides were prepared as described above in 20 mM phos-
phate buffer pH 7.4 (200 mM Na2HPO4, 200 mM NaH2PO4
diluted to 20 mM with ddH2O). Aliquots of the peptides
were taken at 2, 4 and 24 h to assess the progression of fib-
rillisation and morphology. 4 lL of 50 lM peptide solution
was placed on Formvar/carbon film-coated, 400-mesh cop-
per grids (Agar Scientific), allowed to absorb for 1 min and
blotted dry. The grid was washed with 4 lL 0.2 lm milliQ-
filtered water and blotted dry after which 4 lL 2% (w/v)
uranyl acetate was added to the grid for 1 min. The dye
was then blotted dry and the grid was left to air dry. All
grids were examined using a JEOL JEM1400-Plus TEM at
120 kV and the images were captured using a Gatan One-
View 4K camera (Abingdon, UK).
Circular dichroism
150 lL of 50 lM peptide solution was prepared as
described above in 20 mM phosphate buffer. A 1-mm path-
way cuvette (Hellma, Essex, UK) was used for Ab1-42 and
Ab42-1. A 0.5-mm (Hellma) cuvette was used for AbS.
Scans were taken at a scanning speed of 100 nm"min!1,
using a slit width of 1 lm taken between 180 nm and
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320 nm on a JASCO (Essex, UK) J715 Spectropolarimeter.
A water bath was used to equilibrate samples at 20 °C and
the average of three spectra was used for each measure-
ment. Spectral data were converted to molar ellipticity
using the following equation: Mdeg 9 Molecular weight/
(10 9 mg"ml!1 9 pathlength of cuvette 9 number of
amino acids).
Thioflavin T fluorescence
Thioflavin T (10 lM) in 50 lM peptide solution prepared in
20 mM phosphate buffer was added to a 10-mm cuvette. A
Varian Cary Eclipse Fluorescence Spectrophotometer was
used to perform an emission scan between 460 and 600 nm.
Excitation and emission slits were set to 5 and 10 nm
respectively. The sample compartment was kept at a tem-
perature of 21 °C, scan rate was 600 nm"min!1 and the
average of three spectra was used for each measurement.
Cell culture
Rats were housed within a specialised facility under Home
office guidelines and sacrificed using procedures in accor-
dance with Animals (Scientific Procedures) Act 1986,
Amendment Regulations 2012 and with local ethics
approval (University of Sussex Ethical Research commit-
tee). Primary neurons were prepared from P0-1 rats initially
by dissecting tissue into ice cold Hank’s balanced salt solu-
tion (HBSS) containing 0.1 M HEPES. Following washes in
prewarmed Basal Medium Eagle (Gibco, Waltham, MA,
USA) containing 0.5% glucose, 2% FCS, 1 mM sodium-
pyruvate, 0.01 M HEPES pH 7.35, 1% penicillin–strepto-
mycin, 1% B27 supplement and 1% Glutamax, tissues were
triturated using a 1 mL pipette until fully dissociated. The
cell suspension was diluted further with complete Basal
Medium Eagle media and approximately 40 000 cells were
plated into 2-cm2 wells containing a coverslip coated in
20 lg"mL!1 Poly-D-Lysine with a layer of hippocampal
astrocytes that had been growing for 4–5 days. After 2–
3 days, cells were treated with 3.25 lM cytosine arabinoside
to halt further proliferation of astrocytes. Cells were used
10–14 days after plating.
Cell viability assay with primary hippocampal
neurons
Peptides were prepared in 10 mM HEPES buffer (10 mM
HEPES, 50 mM NaCl, 1.6 mM KCL, 2 mM MgCl2, 3.5 mM
CaCl2). After incubation with the peptide for the desired
time, one drop of each Readyprobe reagent (Life Technolo-
gies, Waltham, MA, USA) was added to each well. The
blue stain reagent is used to label all cells and the green
stain reagent is to label only the dead cells. The cells were
incubated with the reagents for the required 15 min before
being imaged on a Zeiss (Cambridge, UK) CO widefield
microscope using DAPI and FITC filters. Analysis was car-
ried out using FIJI software to calculate the percentage of
blue cells that were also stained green. Cells were counted
using the cell counter plug-in and astrocytes were excluded
in the counting. Two coverslips per sample were used and
at least four regions of interest were imaged from each.
The experiment was repeated three independent times.
Results and Discussion
Ab42-1 and AbS assemble to form mature fibrils
with b-sheet structure
WALTZ algorithm, which identifies amyloidogenic
regions using a positional algorithm, was used to pre-
dict the peptides propensity to aggregate [14]. The
graphical trace produced for Ab1-42 highlights two
amyloidogenic regions, while a single region is pre-
dicted for Ab42-1 and AbS is predicted to have no
amyloidogenic regions (Fig. 1).
Using a range of biophysical techniques, the assem-
bly and structure of the two control peptides were
monitored and compared to the wild-type peptide
(Table 1). Peptides were pretreated with hexafluoro-2-
isopropanol (HFIP) and DMSO followed by buffer-
exchange using a spin column to ensure that any
preaggregates and remaining solvents were removed.
Following this, the stock solution of each peptide was
immediately diluted to 50 lM in buffer to ensure con-
sistency and reproducibility between experiments as
changes in concentration can significantly affect
Fig. 1. Graphs produced using WALTZ [14] for Ab1-42, Ab42-1 and
AbS. There are two amyloidogenic regions identified for Ab1-42
between residues 16-21 and 37-42, one region was identified for
Ab42-1 between residues 8 and 13 and no amyloidogenic regions
were identified for AbS.
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assembly. The assembly of the peptides was monitored
over a 7-day period using TEM, CD and ThT fluores-
cence.
Electron microscopy was used to observe the mor-
phology of peptide assemblies over time (Fig. 2). It is
evident that by 24 h, Ab42-1 forms fibrillar structures
though these are less ordered in appearance compared
to those formed by Ab1-42. Interestingly, AbS forms
plaque-like fibrillar networks by 24 h which are only
observed with Ab1-42 after 7 days at the same
concentration [9]. This suggests that not only does AbS
aggregate, but also does so with a higher propensity
than Ab1-42. This result was unexpected as WALTZ
predicted no amyloidogenic regions for AbS. This high-
lights the importance of conducting experimental struc-
tural characterisation. Despite WALTZ being an
excellent tool in predicting peptide amyloidogenic
regions, AbS does assemble which suggests the amy-
loidogenic nature of a peptide is more complex than pri-
mary sequence alone.
Fig. 2. Negative stain transmission electron micrographs with magnified images. Ab1-42 (top row), Ab42-1 (middle row) and AbS (bottom
row) at 2, 4 and 24 h show Ab1-42 assembly from small spherical oligomers to long fibrils by 24 h. Ab42-1 shows slightly larger spherical
species at 2 h which form clumps of fibrils by 4 h. AbS shows small fibrils by 2 h and fibrillar networks by 4 h which are larger by 24 h.
Scale bars 200 nm.
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Circular dichroism was used to investigate the sec-
ondary structure of each peptide over the incubation
time (Fig. 3A–C). CD spectrum from Ab1-42 demon-
strates a conformational change from a random coil
(trough centred at 190 nm) to b-sheet structure
(trough and peak centred at 218 nm and 192 nm
respectively) from 0 to 24 h as previously described
[9]. In comparison, both control peptides show a
strong b-sheet signal almost immediately after prepara-
tion. The spectrum for AbS is initially shifted slightly
towards random coil, suggesting a mixed population,
but displays a strong b-sheet signal by 24 h. These
data indicate that the Ab42-1 and AbS peptides form
initial b-sheet structure rapidly following preparation,
while the wild-type protein transitions from random
coil to b-sheet over a 24-h period under the conditions
used.
Fibrillogenesis was monitored using a ThT fluores-
cence assay (Fig. 3D); both control peptides show a
signal at 483 nm, which indicates the presence of ThT-
positive structures. The spectrum for wild-type Ab
shows a lag phase before a steep increase in intensity,
which then begins to plateau after 20 h of incubation.
This can be explained by nucleation-dependent fibrilli-
sation; the lag phase is the period during which oligo-
mers are generated through a primary pathway and
act as thermodynamically stable nuclei for fibril
growth. Once a critical fibril concentration has been
reached, primary nucleation is overtaken by secondary
nucleation and the surface of these fibrils can act as a
catalyst for the formation of oligomers and further
proliferation into fibrils [15]. This lag and elongation
phase is not observed with either of the control pep-
tides. This is consistent with the results from TEM
and CD which suggest that the peptides assemble very
rapidly after preparation. The lower intensity in ThT
fluorescence at later time points may be attributed to
the loss of peptide from the solution as larger aggre-
gates form and this is supported by the dense fibril
morphology observed in the electron micrographs at
24 h. The ThT fluorescence spectrum for Ab42-1
showed a very shallow increase in intensity, although
fibrils are present in the electron micrographs.
Although different peptide systems are difficult to
Fig. 3. (A–C) CD spectra of (A) Ab1-42, (B) Ab42-1 and (C) AbS respectively. The spectrum for Ab1-42 shows the formation of b-sheet
structure at 24 h, while both Ab42-1 and AbS display spectra for b-sheet structures from T0. (D) ThT fluorescence over time for Ab1-42
( ), Ab42-1 ( ) and AbS ( ). All peptides displayed fluorescence at 483 nm. Ab1-42 shows a lag phase before an increase in
intensity, which then plateaus. Ab42-1 shows a very slight increase in intensity over time and AbS has no lag phase but an increase in
intensity over time, which also plateaus over time. An average of three experiments is shown.
5FEBS Letters (2017) ª 2017 The Authors. FEBS Letters published by John Wiley & Sons Ltd
on behalf of Federation of European Biochemical Societies.
D. M. Vadukul et al. Self-assembly of reversed and scrambled Ab1-42
directly compare using ThT due to differential binding,
it is clear that the ThT intensity increases with incuba-
tion time, suggesting that all three peptides self-assem-
ble to form amyloid fibrils during the timeframe of the
experiment.
To compare the molecular structures of the fibrils
formed by the wild-type and variant peptides, X-ray
fibre diffraction patterns were collected. The fibrils
were partially aligned and the X-ray fibre diffraction
patterns revealed characteristic cross-b diffraction sig-
nals at 4.7 !A and at 10 !A (Fig. S1) consistent with
characteristic cross-b structure for amyloid [16,17].
Unfortunately, the alignment of the samples is insuffi-
cient for detailed conclusions to be drawn regarding
structural similarities or differences between the fibrils
formed by the peptides.
In conclusion, CD and ThT fluorescence combined
with TEM, confirm the presence of b-sheet structure
and fibrillogenesis for all three peptides. Furthermore,
a cross-b pattern from X-ray fibre diffraction confirms
that these control peptides self-assemble and form
bonafide amyloid fibrils.
Neurotoxicity of Ab42-1 and AbS
As described above, oligomeric Ab1-42 is thought to
be the toxic species [10,18,19]. In order to investigate
and compare the potential cytotoxicity of the self-
assembled peptides, a ReadyProbes cell viability assay
(Life Technologies) was conducted. A blue reagent
stain was used to label all cells, while a green reagent
stain labels dead cells only. The percentage of dead
cells in the entire cell population was calculated as a
measure of toxicity. It is important to note that
although cell viability assays are widely used to investi-
gate cytotoxicity, the relationship to AD pathology
Fig. 4. Assessment of cytotoxicity in primary hippocampal cultures treated with peptide at 10 lM and measured using ReadyProbes assay
after 7 days of incubation. (A–C) Electron micrographs of the peptides added to cultures after 2-h incubation. Scale bars and shown. A
magnified image is shown for AbS (B) and arrows point to protofibrillar structures. (D) ReadyProbes assay was conducted after 7 days to
assess toxicity relative to the buffer control (n = 558, dead cells = 52) (P = < 0.05 (*), < 0.01 (**), < 0.0001 (****) and > 0.05 = not
significant). Ab1-42 showed significant cytotoxicity (n = 752, dead cells = 490), Ab42-1 showed no significant cytotoxicity (n = 719, dead
cells = 97) and AbS showed minimal significant cytotoxicity (n = 1627, dead cells = 288).
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may not be closely linked due to the various different
pathways involved in cell death and the specificity of
the assay being used [20]. Nevertheless, as we are
directly investigating the cytotoxicity of these control
peptides in hippocampal neurons and not modelling
AD pathology, we believe the ReadyProbes assay to
be a valid approach. Previously, we developed a
method to prepare oligomeric Ab1-42 by freshly
preparing the peptide, diluting the stock to 50 lM and
incubating it at room temperature for 2 h before add-
ing to rat hippocampal neurons [9]. The cell death
assay was then conducted after 7 days of incubation in
the presence of the peptide. Here, identical methods of
preparation were used for both control peptides and
compared to the hippocampal neurons incubated with
wild-type Ab1-42. Electron micrographs were also pre-
pared in order to visualise morphologies of the pep-
tides at the time point at which the peptide was added
to the neurons (Fig. 4A-C).
Ab1-42 generally causes 65% (SEM # 3.24, ‘****’)
cytotoxicity after 7 days of incubation compared to the
buffer only condition that showed only 10% cell death
(SEM # 2.75) (Fig. 4D). In comparison, AbS and
Ab42-1 demonstrated less potent toxicity than wild-type
peptide at the same time point and using the identical
preparation conditions; 17% (SEM # 1.55,‘*’) and
14% (SEM # 1.86) respectively. Previous studies have
also shown that Ab42-1 [21] and AbS (identical
sequence to AbS used here from Anachem) [11] are
inactive in cellular assays. Electron micrographs taken
2 h after preparation offer an explanation for the differ-
ence in cytotoxicity of these peptides. The wild-type
Ab1-42 shows small spherical species, which we identify
as oligomers. In contrast, electron micrographs of
Ab42-1 and AbS taken at the same time point show
some larger aggregates, protofibrils and some fibrils. It
appears that reverse and scrambled variants of Ab1-42
self-assemble to form fibrillar structures more rapidly
than wild-type and these are much less toxic than the
oligomeric wild-type peptide. Previous work has linked
internalisation of oligomers with toxicity and therefore
one hypothesis for the reduced toxic nature of these
peptides is that these structures are less able to enter the
neurons [9,22] and cause their downstream toxic effects
due to their increased size. The inability for cells to take
up AbS has been previously reported [23], as has the
nonapoptotic effects [24] and Ab42-1 [25]. This supports
the view that toxicity of amyloidogenic proteins is
tightly linked to assembly size and structure. It has pre-
viously been reported that the uptake of aggregating
amyloid proteins is sequence specific [26], and the cellu-
lar response to these proteins is thought to be highly
dependent on aggregation propensity, size and charge.
As the sequences of both control peptides have led to a
higher propensity to aggregate than wild-type Ab1-42,
confirmed by structural characterisation presented
above, the reported mechanisms of internalisation,
which include dynamin-mediated endocytosis [27], may
not be possible with the control peptides. Alternatively,
the specific order of amino acids in Ab42-1 and AbS
may affect binding to receptors or assembly into specific
oligomeric species that are required for toxicity.
Conclusions
Although both Ab42-1 and AbS have been used in
many studies as experimental controls for Ab1-42,
these results suggest their validity should be ques-
tioned. If conclusions are to be made regarding the
effects of amyloidogenic proteins, it is desirable for
controls to be sequence related but ideally show no
propensity for self-assembly. We have previously pre-
sented a sequence-related, nonaggregating variant of
Ab1-42 [9] as a comparison to these traditional con-
trols and also as an example of a more suitable con-
trol. To critically evaluate and continually develop our
experimental controls in this way will ultimately aid
our understanding of the mechanisms involved in AD.
Furthermore, by characterising assembly and relating
this to toxicity, our findings suggest that the toxic nat-
ure of these amyloid proteins is likely to be related to
size and sequence. WALTZ predicted both control
peptides to have fewer amyoidogenic regions than the
wild-type; Ab42-1 was predicted to have one amy-
loidogenic region, whereas AbS was predicted to have
none. Despite this, both peptides show assembly and
similar noncytotoxic behaviour in cells. We suggest
that this is due to the lack of oligomeric species
formed by both control peptides, which supports the
view that Ab1-42 oligomers represent the toxic entity.
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